CompletedNCT00749203
Ketamine or midazolam for rapid PTSD symptom relief
About this title
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Read the official source — NCT00749203Medication studyAges 21–55United States
Understand this study
Who was this study for?
This study was for people with PTSD. Listed age limits: 21 years to 55 years. Other eligibility criteria applied.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJanuary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 41
- Sponsor
- Dennis Charney
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT00749203
- Official title
Show the full official title
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Dennis Charney.
Did this study involve medication?
Yes. The study involved medication, including Midazolam and ketamine.
Who was this study for?
This study was for people with PTSD. Listed age limits: 21 years to 55 years. Other eligibility criteria applied.
